Task order no. 3 miller LO - medicinal chemistry support program for therapeutic development
Ended Awarded Last action
- Contract number
- 75N95018F00003
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,297,588
Award facts
- Opportunity
-
- NIHNINDS1701 Solicitation number
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Mar 19, 2018
- Medicinal Chemistry Support Program for Therapeutic Development (MCSP) Award Notice · Posted Jun 30, 2017
- Contract value 100% obligated
- $1,297,587.74 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$22,641 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,320,229 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,297,587.74 cost-plus-fixed-fee delivery order to Curia Global Inc. (doing business as Amri) for the Medicinal Chemistry Support Program for Therapeutic Development. This program supports medicinal chemistry and other drug discovery and development services to advance treatments for conditions such as Alzheimer's disease, Parkinson's disease, pain, substance abuse, and infectious diseases. The contract has no set-aside designation. Curia, a leading contract development and manufacturing organization, has supported various NIH entities through prime and subcontract awards on indefinite-delivery, indefinite-quantity vehicles for drug discovery and pharmaceutical research and development services.
Quick answers
Who was awarded contract 75N95018F00003?
75N95018F00003 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2018.
How much is contract 75N95018F00003 worth?
The government has obligated $1,297,588 on 75N95018F00003.
Is contract 75N95018F00003 an order under another contract?
Yes. 75N95018F00003 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95018F00003 competed?
The extent of competition for 75N95018F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award